Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Tamoxifen

Known as: Tamoxifeno, TAM, (Z)-2-[4(1,2-diphenyl-1-butenyl)-phenoxyl]-N,N-dimethylethanamine 
An antineoplastic nonsteroidal selective estrogen receptor modulator (SERM). Tamoxifen competitively inhibits the binding of estradiol to estrogen… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2005
Highly Cited
2005
BACKGROUND The aromatase inhibitor letrozole is a more effective treatment for metastatic breast cancer and more effective in the… Expand
  • table 1
  • figure 1
  • table 2
  • figure 2
  • figure 3
Highly Cited
2004
Highly Cited
2004
BACKGROUND The likelihood of distant recurrence in patients with breast cancer who have no involved lymph nodes and estrogen… Expand
  • figure 1
  • table 1
  • figure 2
  • table 2
  • table 3
Highly Cited
2004
Highly Cited
2004
BACKGROUND Tamoxifen, taken for five years, is the standard adjuvant treatment for postmenopausal women with primary, estrogen… Expand
  • figure 1
  • table 1
  • table 2
  • figure 2
  • table 3
Highly Cited
2003
Highly Cited
2003
A separate and distinct interaction with both the actual e-vendor and with its IT Web site interface is at the heart of online… Expand
  • figure 1
  • table 1
  • table 1
  • table 1
  • table 2
Highly Cited
2003
Highly Cited
2003
BACKGROUND Tamoxifen, a selective estrogen receptor modulator (SERM), is converted to 4-hydroxy-tamoxifen and other active… Expand
  • figure 1
  • figure 2
  • figure 4
  • figure 3
  • figure 5
Highly Cited
2002
Highly Cited
2002
BACKGROUND In the adjuvant setting, tamoxifen is the established treatment for postmenopausal women with hormone-sensitive breast… Expand
  • figure 1
  • table 1
  • table 2
  • figure 3
  • figure 2
Highly Cited
1998
Highly Cited
1998
BACKGROUND The finding of a decrease in contralateral breast cancer incidence following tamoxifen administration for adjuvant… Expand
  • figure 1
  • table 1
  • table 2
  • figure 2
  • table 3
Review
1998
Review
1998
BACKGROUND There have been many randomised trials of adjuvant tamoxifen among women with early breast cancer, and an updated… Expand
Highly Cited
1998
Highly Cited
1998
Ligand-dependent activation of transcription by nuclear receptors (NRs) is mediated by interactions with coactivators. Receptor… Expand
  • figure 1
  • table 1
  • figure 4
  • figure 5
  • figure 6
Highly Cited
1998
Highly Cited
1998
Breast cancer is the most common cancer in women in the Western world. Because breast cancer is estrogen-dependent, reducing… Expand